Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP636717.RABez6UWyZmXAld4H_Jt1iyOvdrK197x-E_b-KFR6G2YU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP636717.RABez6UWyZmXAld4H_Jt1iyOvdrK197x-E_b-KFR6G2YU130_assertion type Assertion NP636717.RABez6UWyZmXAld4H_Jt1iyOvdrK197x-E_b-KFR6G2YU130_head.
- NP636717.RABez6UWyZmXAld4H_Jt1iyOvdrK197x-E_b-KFR6G2YU130_assertion description "[VEGFA and FGF2 positivities and MVC were lower in MSI-H cancers than in MSI-L or MSS cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP636717.RABez6UWyZmXAld4H_Jt1iyOvdrK197x-E_b-KFR6G2YU130_provenance.
- NP636717.RABez6UWyZmXAld4H_Jt1iyOvdrK197x-E_b-KFR6G2YU130_assertion evidence source_evidence_literature NP636717.RABez6UWyZmXAld4H_Jt1iyOvdrK197x-E_b-KFR6G2YU130_provenance.
- NP636717.RABez6UWyZmXAld4H_Jt1iyOvdrK197x-E_b-KFR6G2YU130_assertion SIO_000772 17374440 NP636717.RABez6UWyZmXAld4H_Jt1iyOvdrK197x-E_b-KFR6G2YU130_provenance.
- NP636717.RABez6UWyZmXAld4H_Jt1iyOvdrK197x-E_b-KFR6G2YU130_assertion wasDerivedFrom befree-20140225 NP636717.RABez6UWyZmXAld4H_Jt1iyOvdrK197x-E_b-KFR6G2YU130_provenance.
- NP636717.RABez6UWyZmXAld4H_Jt1iyOvdrK197x-E_b-KFR6G2YU130_assertion wasGeneratedBy ECO_0000203 NP636717.RABez6UWyZmXAld4H_Jt1iyOvdrK197x-E_b-KFR6G2YU130_provenance.